Stephen Parodi, MD, warns of potential post-holiday COVID-19 surge on CNBC
Kaiser Permanente's national infectious disease leader urges people to adjust their behavior to prevent a new wave of COVID-19 cases from the holidays.
Stephen Parodi, MD, welcomes news of COVID-19 vaccine approvals on CNBC
Kaiser Permanente's national infectious disease leader underscores the safety of recently approved COVID-19 vaccines and the importance of avoiding holiday travel.
CNBC interviews Edward M. Ellison, MD, about remdesivir, pandemic’s impact on physicians
In a wide-ranging interview Friday with CNBC about COVID-19, Edward M. Ellison, MD, executive medical director and chairman of Southern California Permanente Medical Group, characterized the remdesivir clinical trial as “encouraging.”
Edward M. Ellison, MD, shares coronavirus surge scenario planning with CNBC
Edward M. Ellison, MD, co-CEO of The Permanente Federation, shared on a CNBC broadcast the many ways in which the Permanente Medical Groups have been planning aggressively for a surge of coronavirus patients.
Pat Conolly, MD, Touts Kaiser Permanente’s Digital Engagement with Patients in CNBC Story
CNBC reported Saturday on the use of telemedicine by health care organizations, and quoted Pat Conolly, MD, The Permanente Federation’s chief information officer.